Margarita Perez-Barrientos

Av. Kepler 2143, Cons. 715 B, Col. Reserva Territorial Atlixcayotl, CP 72190
Puebla, PUE 72190, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Diagnostic criteria for growth disorders requiring growth hormone therapy: updated consensus from the Sociedad Mexicana de Endocrinología Pediátrica.

Diagnostic criteria for growth disorders requiring growth hormone therapy: updated consensus from the Sociedad Mexicana de Endocrinología Pediátrica.

Journal: Boletin medico del Hospital Infantil de Mexico

Published: June 11, 2026

Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial.

Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial.

Journal: Lancet (London, England)

Published: August 01, 2025

ISPAD Clinical Practice Consensus Guidelines 2024: Type 2 Diabetes in Children and Adolescents.

ISPAD Clinical Practice Consensus Guidelines 2024: Type 2 Diabetes in Children and Adolescents.

Journal: Hormone research in paediatrics

Published: November 01, 2024

Liraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial.

Liraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial.

Journal: The New England journal of medicine

Published: September 11, 2024

Once-Weekly Semaglutide in Adolescents with Obesity.

Once-Weekly Semaglutide in Adolescents with Obesity.

Journal: The New England journal of medicine

Published: November 02, 2022

Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes.

Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes.

Journal: The New England journal of medicine

Published: June 03, 2022

A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes.

A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes.

Journal: Pediatric diabetes

Published: November 19, 2021

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity.

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity.

Journal: The New England journal of medicine

Published: April 02, 2020

Country-Specific Prevalence and Incidence of Youth-Onset Type 2 Diabetes: A Narrative Literature Review.

Country-Specific Prevalence and Incidence of Youth-Onset Type 2 Diabetes: A Narrative Literature Review.

Journal: Annals of nutrition & metabolism

Published: December 20, 2019

Recommendations for improving clinical trial design to facilitate the study of youth-onset type 2 diabetes.

Recommendations for improving clinical trial design to facilitate the study of youth-onset type 2 diabetes.

Journal: Clinical trials (London, England)

Published: August 28, 2019

Liraglutide in Children and Adolescents with Type 2 Diabetes.

Liraglutide in Children and Adolescents with Type 2 Diabetes.

Journal: The New England journal of medicine

Published: April 30, 2019

Youth-Onset Type 2 Diabetes Manifestations in other Specialties: Its Many Disguises.

Youth-Onset Type 2 Diabetes Manifestations in other Specialties: Its Many Disguises.

Journal: Annals of nutrition & metabolism

Published: January 11, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026